No significant benefit of moderate-dose vitamin C on severe COVID-19 cases

There is no specific drug for coronavirus disease 2019 (COVID-19). We aimed to investigate the possible clinical efficacy of moderate-dose vitamin C infusion among inpatients with severe COVID-19. Data of 397 adult patients with severe COVID-19 admitted to a designated clinical center of Wuhan Union...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Shaoping, Chen, Qiaosen, Jiang, Hongbo, Guo, Chunxia, Luo, Jinzhuo, Li, Sumeng, Wang, Hua, Li, Huadong, Zheng, Xin, Weng, Zhihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459914/
https://www.ncbi.nlm.nih.gov/pubmed/34616916
http://dx.doi.org/10.1515/med-2021-0361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459914/
https://www.ncbi.nlm.nih.gov/pubmed/34616916
http://dx.doi.org/10.1515/med-2021-0361

Ejemplares similares